[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:transformed-follicular-lymphoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":62,"states":63},"Transformed Follicular Lymphoma",8,5,[8,16,22,28,35,41,49,56],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04889716","CAR-T Followed by Bispecific Antibodies",[12],"Phase 2","RECRUITING","2026-08-26T02:19:00.742020Z","2026-07-05T05:32:16.799310Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06788964","Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)",[12],"2026-08-26T02:18:45.196599Z","2026-07-05T05:32:16.700465Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06285825","A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia",[12],"2026-08-26T02:16:03.788292Z","2026-05-05T02:43:28.728703Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT05826535","Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma",[32],"Phase 1\u002FPhase 2","2026-08-26T02:19:30.857183Z","2026-05-05T02:43:28.542914Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06144151","A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity",[],"2026-08-26T02:16:01.079019Z","2026-05-13T02:55:06.421955Z",{"nct_id":42,"title":43,"phases":44,"status":46,"updated_at":47,"content_modified":48},"NCT07168486","CD19.20.22 CAR T-cells for Patients With Relapsed\u002FRefractory B-Cell Lymphomas",[45],"Phase 1","ENROLLING_BY_INVITATION","2026-08-26T02:19:19.975067Z","2026-06-16T05:54:07.870155Z",{"nct_id":50,"title":51,"phases":52,"status":53,"updated_at":54,"content_modified":55},"NCT06014762","P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies",[45],"ACTIVE_NOT_RECRUITING","2026-08-03T02:04:34.624671Z","2026-05-05T02:43:27.986911Z",{"nct_id":57,"title":58,"phases":59,"status":53,"updated_at":60,"content_modified":61},"NCT05821088","Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed\u002F Refractory Large B-Cell Lymphoma",[12],"2026-08-03T03:19:35.241322Z","2026-05-05T02:43:26.683044Z",[],[64,68,72],{"state":65,"count":66,"slug":67},"Texas",4,"texas",{"state":69,"count":70,"slug":71},"Ohio",3,"ohio",{"state":73,"count":70,"slug":74},"Pennsylvania","pennsylvania"]